Yatsen is a leader in the rapidly evolving China beauty market. Founded in 2016, we have launched three fast-growing, successful color cosmetics and skincare brands: Perfect Diary, Little Ondine and Abby’s Choice. Together, these three brands served 23.4 million and 23.5 million DTC (direct-to-consumer) customers in 2019 and the nine months ended Sept. 30, 2020, respectively. Our first brand, Perfect […]

This is the fifth blank-check company formed by Betsy Z. Cohen, a founder and the former CEO of The Bancorp (NASDAQ: TBBK); her son, Daniel G. Cohen, the president and CEO of the European business of Cohen and Company, Inc. (NYSE: COHN), a financial services company with about $2.63 billion in assets under management as […]

We intend to focus on opportunities that capitalize on the expertise and ability of our team, particularly our executive officers, to identify, acquire and operate a business in the broadly defined sustainability industry. This industry includes, but is not limited to, energy and power (with a focus on renewable energy, biofuels and energy storage), resource […]

We will focus on companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. We intend to capitalize on the unique mix of experience and highly complementary capabilities of our co-founders, Clive Meanwell and Ian Read, as well as our management team, in leading, operating and strategically positioning […]

(IPOScoop has No Call on this initial public offering. Please see this statement in the prospectus: “Until recently, our Ordinary Shares traded on the Australian Securities Exchange operated by ASX Ltd. (or ASX), under the symbol “GMV.” On October 22, 2020, our Ordinary Shares were voluntarily delisted from the ASX. We have been approved to […]

We are a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines, and to support research on human diseases. Our more than 5,000 customers as of Sept. 30, 2020 include the top 20 global biopharmaceutical companies ranked by research and development expenditures according to industry consultants, […]

While we may pursue a business combination target in any business or industry, we intend to focus on global companies in telecom, media and technology (“TMT”), healthcare, fintech and consumer sectors with compelling Asian growth potential. We believe our management team and directors have the relevant skills and experience to identify companies that can best […]

We intend to focus our search on identifying a prospective target that can benefit from our operational expertise in the technology, media and telecommunications (“TMT”) industry, including the wireless communications industry.    Our founder and chairman, Charles W. Ergen, is one of the most prominent and respected figures in the TMT industry with extensive experience […]

We intend to focus our search for a target business in the consumer sector. We believe our management team is well suited to identify opportunities that have the potential to generate attractive risk-adjusted returns for our shareholders, although we may pursue a business combination opportunity in any business or industry. Our company was founded by senior […]

We intend to focus our search for a target business in the energy industry in North America. Each member of our management team has nearly 30 years average experience in the energy industry: *J. Douglas Ramsey, Ph.D., our chairman and CEO, was the president and CFO of Saddle Operating, LLC, a private acquisition and production […]